References
Sultan SM, Isenberg DA (2010) Re-classifying myositis. Rheumatology (Oxford) 49(5):831–833
Gunawardena H, Betteridge ZE, McHugh NJ (2009) Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 48(6):607–612
Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK et al (2009) Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest 135(6):1550–1556
Hervier B, Wallaert B, Hachulla E, Adoue D, Lauque D, Audrain M et al (2010) Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology (Oxford) 49(5):972–976
Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ (2010) Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J. doi:10.1111/j.1445-5994.2010.02164.x
Targoff IN, Arnett FC (1990) Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 88(3):241–251
Conflicts of interest
All authors declare no conflicts of interest or disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mehta, P., Patel, L., Roncaroli, F. et al. Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies. Rheumatol Int 32, 825–827 (2012). https://doi.org/10.1007/s00296-011-1811-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1811-4